Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors

Meiotic failure is a major cause of infertility, but the lack of an in vitro model of human meiosis is a barrier to understanding its mechanism. Here, we establish a method to initiate meiosis directly from male or female human-induced pluripotent stem cells (iPSCs). DNMT1 inhibition, retinoid signaling activation, and overexpression of regulatory factors (antiapoptotic BCL2 and promeiotic HOXB5, BOLL, or MEIOC) rapidly activates meiosis over a 15-day protocol. Our protocol bypasses the primordial germ cell stage and directly generates cells expressing genes similar to meiotic oogonia, including oogonia markers, all synaptonemal complex components, and meiotic recombination machinery. DNMT1 inhibition rapidly erases DNA methylation, including at imprinting control regions and promoters of meiotic genes. Microscopy shows key aspects of meiosis, including chromosome axis formation and synapsis in live human cells. Our model of human meiosis provides opportunities for studying this critical reproductive process under chemically defined conditions in vitro.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2025-08-15
DOI
https://doi.org/10.1126/sciadv.adu0384
Citations
8
Primary Topic
CRISPR and Genetic Engineering
Type
article
Field-Weighted Citation Impact
6.45
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors

Toshi Shioda, Merrick Pierson Smela, Laura Breimann, Ursula Widocki et al.
8 citations
Science Advances
CRISPR and Genetic Engineering
6.45
article

Initiation of meiosis from human iPSCs under defined conditions through identification of regulatory factors

Toshi Shioda, Merrick Pierson Smela, Laura Breimann, Ursula Widocki, Carl Ma, Jessica Adams, Bogdan Dobre
article en
8 citations

Abstract

Meiotic failure is a major cause of infertility, but the lack of an in vitro model of human meiosis is a barrier to understanding its mechanism. Here, we establish a method to initiate meiosis directly from male or female human-induced pluripotent stem cells (iPSCs). DNMT1 inhibition, retinoid signaling activation, and overexpression of regulatory factors (antiapoptotic BCL2 and promeiotic HOXB5, BOLL, or MEIOC) rapidly activates meiosis over a 15-day protocol. Our protocol bypasses the primordial germ cell stage and directly generates cells expressing genes similar to meiotic oogonia, including oogonia markers, all synaptonemal complex components, and meiotic recombination machinery. DNMT1 inhibition rapidly erases DNA methylation, including at imprinting control regions and promoters of meiotic genes. Microscopy shows key aspects of meiosis, including chromosome axis formation and synapsis in live human cells. Our model of human meiosis provides opportunities for studying this critical reproductive process under chemically defined conditions in vitro.

Science AdvancesVol. 11(33)
Broad Institute (US), Harvard University (US), ProterixBio (United States) (US), Center for Cancer Research (US)
Openalex Percentile: Top 3%
CRISPR and Genetic Engineering
6.45
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.